This study evaluates the Speech Intelligibility Index (SII) as a tool to describe hearing loss and predict when hearing aids would be appropriate for pediatric oncology patients who have received or are currently receiving cisplatin. The efficacy of the SII is compared to the Brock grade which is commonly used for patients with ototoxic hearing loss secondary to cisplatin treatment. The SII is a discrete measure that precisely reflects the patient’s functional hearing status and is highly correlated with the need for audiologic intervention.
Program in Audiology and Communication Sciences, Washington University School of Medicine
Hearing Aids; Cisplatin
Cahill, Megan, "Efficacy of the Speech Intelligibility Index as an intervention tool with pediatric cancer patients" (2010). Independent Studies and Capstones. Paper 612. Program in Audiology and Communication Sciences, Washington University School of Medicine.